BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Timmermans-Sprang EP, Gracanin A, Mol JA. High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression. BMC Cancer 2015;15:545. [PMID: 26205886 DOI: 10.1186/s12885-015-1544-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Bernard S, Poon AC, Tam PM, Mutsaers AJ. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells. BMC Vet Res 2021;17:382. [PMID: 34895222 DOI: 10.1186/s12917-021-03089-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yin Y, Shi L, Yang J, Wang H, Yang H, Wang Q. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells. Bioengineered 2022;13:107-18. [PMID: 34818980 DOI: 10.1080/21655979.2021.2009411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Pawlak A, Bajzert J, Bugiel K, Hernández Suárez B, Kutkowska J, Rapak A, Hildebrand W, Obmińska-Mrukowicz B, Freire R, Smits VAJ. Ubiquitin-specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies. J Vet Intern Med 2021;35:1041-51. [PMID: 33650720 DOI: 10.1111/jvim.16082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Roy KR, Uddin MB, Roy SC, Hill RA, Marshall J, Li YT, Chamcheu JC, Lu H, Liu YY. Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation. FASEB Bioadv 2020;2:653-67. [PMID: 33205006 DOI: 10.1096/fba.2020-00044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Reddy D, Kumavath R, Ghosh P, Barh D. Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways. Biomolecules 2019;9:E792. [PMID: 31783627 DOI: 10.3390/biom9120792] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
6 Zhang C, Zhang M, Ge S, Huang W, Lin X, Gao J, Gong J, Shen L. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer Med 2019;8:4766-81. [PMID: 31243897 DOI: 10.1002/cam4.2360] [Cited by in Crossref: 132] [Cited by in F6Publishing: 138] [Article Influence: 44.0] [Reference Citation Analysis]
7 Timmermans-Sprang EPM, Mestemaker HM, Steenlage RR, Mol JA. Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signalling. Vet Comp Oncol 2019;17:413-26. [PMID: 31069942 DOI: 10.1111/vco.12490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Niu J, Wang X, Liang C, Zhang YD, Liu FY, Li HY, Xie SQ, Sun H, Fang D. Suppression of epidermal growth factor receptor-mediated β-catenin nuclear accumulation enhances the anti-tumor activity of phosphoinositide 3-kinase inhibitor in breast cancer. Cell Biol Int 2019;43:931-9. [PMID: 31124219 DOI: 10.1002/cbin.11183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Timmermans-Sprang E, Collin R, Henkes A, Philipsen M, Mol JA. P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines. Oncotarget 2019;10:2930-46. [PMID: 31105876 DOI: 10.18632/oncotarget.26873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Li W, Hou JZ, Niu J, Xi ZQ, Ma C, Sun H, Wang CJ, Fang D, Li Q, Xie SQ. Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation. Cell Commun Signal 2018;16:82. [PMID: 30445978 DOI: 10.1186/s12964-018-0295-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
11 Pandey M, Sunil Kumar BV, Gupta K, Sethi RS, Kumar A, Verma R. Over-expression of mammaglobin-B in canine mammary tumors. BMC Vet Res 2018;14:184. [PMID: 29903015 DOI: 10.1186/s12917-018-1507-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao B, Zhao Y, Sun Y, Niu H, Sheng L, Huang D, Li L. Alterations in mRNA profiles of trastuzumab‑resistant Her‑2‑positive breast cancer. Mol Med Rep 2018;18:139-46. [PMID: 29750305 DOI: 10.3892/mmr.2018.8981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers. Oncotarget 2017;8:3072-103. [PMID: 27902969 DOI: 10.18632/oncotarget.13618] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
14 Zhou Q, Jin P, Liu J, Wang F, Xi S. HER2 and Src co-regulate proliferation, migration and transformation by downstream signaling pathways in arsenite-treated human uroepithelial cells. Metallomics 2018;10:1141-59. [DOI: 10.1039/c8mt00131f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sunil Kumar BV, Bhardwaj R, Mahajan K, Kashyap N, Kumar A, Verma R. The overexpression of Hsp90B1 is associated with tumorigenesis of canine mammary glands. Mol Cell Biochem 2018;440:23-31. [DOI: 10.1007/s11010-017-3152-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda J, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells. Breast Cancer Res Treat 2017;166:55-68. [DOI: 10.1007/s10549-017-4382-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
17 Timmermans-Sprang EPM, Gracanin A, Mol JA. Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification. Front Vet Sci 2017;4:53. [PMID: 28451590 DOI: 10.3389/fvets.2017.00053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]